HIGHLIGHTS
- who: August et al. from the China Medical, China China have published the research work: Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I III lung squamous cell carcinoma, in the Journal: (JOURNAL)
- what: The authors compared immune cell infiltration To further verify the results of the bioinformatic analysis, the expression levels of CCL15 and PPBP were validated by qRT‒ PCR in clinical tumor specimens. The study provides insight into the multifaceted role of the chemokine signaling pathway in LUSC and may help clinicians implement . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.